| The global burden of metabolic disease: Data from 2000 to 2019 NWS Chew, CH Ng, DJH Tan, G Kong, C Lin, YH Chin, WH Lim, ... Cell Metabolism 35 (3), 414-428. e3, 2023 | 392 | 2023 |
| Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis J Quek, KE Chan, ZY Wong, C Tan, B Tan, WH Lim, DJH Tan, ASP Tang, ... The lancet Gastroenterology & hepatology 8 (1), 20-30, 2023 | 383 | 2023 |
| Global incidence and prevalence of nonalcoholic fatty liver disease MLP Teng, CH Ng, DQ Huang, KE Chan, DJH Tan, WH Lim, JD Yang, ... Clinical and molecular hepatology 29 (Suppl), S32, 2022 | 332 | 2022 |
| Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta … DJH Tan, CH Ng, SY Lin, XH Pan, P Tay, WH Lim, M Teng, N Syn, G Lim, ... The Lancet Oncology 23 (4), 521-530, 2022 | 238 | 2022 |
| Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals KE Chan, TJL Koh, ASP Tang, J Quek, JN Yong, P Tay, DJH Tan, WH Lim, ... The Journal of Clinical Endocrinology & Metabolism 107 (9), 2691-2700, 2022 | 196 | 2022 |
| An observational data meta-analysis on the differences in prevalence and risk factors between MAFLD vs NAFLD GEH Lim, A Tang, CH Ng, YH Chin, WH Lim, DJH Tan, JN Yong, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (3), 619-629. e7, 2023 | 189 | 2023 |
| The unspoken reality of gender bias in surgery: a qualitative systematic review WH Lim, C Wong, SR Jain, CH Ng, CH Tai, MK Devi, DD Samarasekera, ... PLoS One 16 (2), e0246420, 2021 | 130 | 2021 |
| Mortality outcomes by fibrosis stage in nonalcoholic fatty liver disease: a systematic review and meta-analysis CH Ng, WH Lim, GEH Lim, DJH Tan, N Syn, MD Muthiah, DQ Huang, ... Clinical Gastroenterology and Hepatology 21 (4), 931-939. e5, 2023 | 109 | 2023 |
| The perspectives of health professionals and patients on racism in healthcare: A qualitative systematic review W Sim, WH Lim, CH Ng, YH Chin, CYL Yaow, CWZ Cheong, CM Khoo, ... PLoS One 16 (8), e0255936, 2021 | 103 | 2021 |
| Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis EEL Cho, CZ Ang, J Quek, CE Fu, LKE Lim, ZEQ Heng, DJH Tan, WH Lim, ... Gut 72 (11), 2138-2148, 2023 | 97 | 2023 |
| Patterns in cancer incidence among people younger than 50 years in the US, 2010 to 2019 B Koh, DJH Tan, CH Ng, CE Fu, WH Lim, RW Zeng, JN Yong, JH Koh, ... JAMA Network Open 6 (8), e2328171-e2328171, 2023 | 96 | 2023 |
| The association of plant-based diet with cardiovascular disease and mortality: a meta-analysis and systematic review of prospect cohort studies J Quek, G Lim, WH Lim, CH Ng, WZ So, J Toh, XH Pan, YH Chin, ... Frontiers in cardiovascular medicine 8, 756810, 2021 | 93 | 2021 |
| Global burden of liver cancer in males and females: changing etiological basis and the growing contribution of NASH DJH Tan, VW Setiawan, CH Ng, WH Lim, MD Muthiah, EX Tan, YY Dan, ... Hepatology 77 (4), 1150-1163, 2023 | 92 | 2023 |
| The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019 B Chong, G Kong, K Shankar, HSJ Chew, C Lin, R Goh, YH Chin, ... Metabolism 141, 155402, 2023 | 87 | 2023 |
| Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: an updated meta-analysis with 135,602 individuals ASP Tang, KE Chan, J Quek, J Xiao, P Tay, M Teng, KS Lee, SY Lin, ... Clinical and Molecular Hepatology 28 (3), 483, 2022 | 83 | 2022 |
| Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD-a systematic review and meta-analysis A Tang, CH Ng, PH Phang, KE Chan, YH Chin, CE Fu, RW Zeng, J Xiao, ... Clinical Gastroenterology and Hepatology 21 (7), 1750-1760. e12, 2023 | 73 | 2023 |
| Is fatty liver associated with depression? A meta-analysis and systematic review on the prevalence, risk factors, and outcomes of depression and non-alcoholic fatty liver disease J Xiao, LKE Lim, CH Ng, DJH Tan, WH Lim, CSH Ho, EXX Tan, AJ Sanyal, ... Frontiers in medicine 8, 691696, 2021 | 67 | 2021 |
| The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease CH Ng, KE Chan, YH Chin, RW Zeng, PC Tsai, WH Lim, DJH Tan, ... Clinical and molecular hepatology 28 (3), 565, 2022 | 60 | 2022 |
| Metabolic associated fatty liver disease increases the risk of systemic complications and mortality. A meta-analysis and systematic review of 12 620 736 individuals J Quek, CH Ng, ASP Tang, N Chew, M Chan, CM Khoo, CP Wei, YH Chin, ... Endocrine Practice 28 (7), 667-672, 2022 | 59 | 2022 |
| Meta‐analysis: chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin RW Zeng, JN Yong, DJH Tan, CE Fu, WH Lim, J Xiao, KE Chan, C Tan, ... Alimentary pharmacology & therapeutics 57 (6), 600-609, 2023 | 57 | 2023 |
